• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剪接因子HNRNPH1调控Circ-MYOCD反向剪接以调节心肌肥大进程

[The splicing factor HNRNPH1 regulates Circ-MYOCD back-splicing to modulate the course of cardiac hypertrophy].

作者信息

Cai Rui, Huang Zhuo, He Wenxia, Ai Tianhong, Song Xiaowei, Hu Shuting

机构信息

School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.

Department of Cardiology,First Affiliated Hospital,Naval Medical University, Shanghai 200433, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2025 Mar 20;45(3):587-594. doi: 10.12122/j.issn.1673-4254.2025.03.16.

DOI:10.12122/j.issn.1673-4254.2025.03.16
PMID:40159973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11955894/
Abstract

OBJECTIVES

To explore the mechanism of Circ-MYOCD back-splicing and its regulatory role in myocardial hypertrophy.

METHODS

Sanger sequencing and RNase R assays were performed to verify the circularity and stability of Circ-MYOCD, whose subcellular distribution was determined by nuclear-cytoplasmic fractionation. Bioinformatics analysis and mass spectrometry from pull-down assays were conducted to predict the RNA-binding proteins (RBPs) interacting with Circ-MYOCD. In rat cardiomyocytes H9C2 cells, the effects of HNRNPH1 and HNRNPL knockdown and overexpression on Circ-MYOCD back-splicing were evaluated. In a H9C2 cell model of angiotensin II (Ang II)-induced myocardial hypertrophy, the expression of HNRNPH1 was detected, the effects of HNRNPH1 knockdown and overexpression on progression of myocardial hypertrophy were assessed, and the regulatory effect of HNRNPH1 on Circ-MYOCD back-splicing was analyzed.

RESULTS

Sanger sequencing confirmed that the junction primers could amplify the correct Circ-MYOCD sequence. RNase R and nuclear-cytoplasmic fractionation assays showed that Circ-MYOCD was stable and predominantly localized in the cytoplasm. Bioinformatics analysis and mass spectrometry from the Circ-MYOCD pull-down assay identified HNRNPH1 and HNRNPL as the RBPs interacting with Circ-MYOCD. In H9C2 cells, HNRNPH1 knockdown significantly enhanced while its overexpression inhibited Circ-MYOCD back-splicing; HNRNPH1 overexpression obviously increased the expressions of myocardial hypertrophy markers ANP and BNP, while its knockdown produced the opposite effect. In Ang II-induced H9C2 cells, which exhibited a significant increase of HNRNPH1 expression and increased expressions of ANP and BNP, HNRNPH1 knockdown obviously increased Circ-MYOCD expression, decreased MYOCD expression and lowered both ANP and BNP expressions.

CONCLUSIONS

HNRNPH1 regulates Circ-MYOCD back-splicing to influence the progression of myocardial hypertrophy.

摘要

目的

探讨Circ-MYOCD反向剪接的机制及其在心肌肥大中的调控作用。

方法

进行桑格测序和RNase R分析以验证Circ-MYOCD的环化和稳定性,通过细胞核-细胞质分级分离确定其亚细胞分布。进行生物信息学分析和下拉试验的质谱分析以预测与Circ-MYOCD相互作用的RNA结合蛋白(RBP)。在大鼠心肌细胞H9C2细胞中,评估HNRNPH1和HNRNPL敲低及过表达对Circ-MYOCD反向剪接的影响。在血管紧张素II(Ang II)诱导的心肌肥大H9C2细胞模型中,检测HNRNPH1的表达,评估HNRNPH1敲低及过表达对心肌肥大进展的影响,并分析HNRNPH1对Circ-MYOCD反向剪接的调控作用。

结果

桑格测序证实连接引物可扩增出正确的Circ-MYOCD序列。RNase R和细胞核-细胞质分级分离试验表明Circ-MYOCD稳定且主要定位于细胞质中。Circ-MYOCD下拉试验的生物信息学分析和质谱分析确定HNRNPH1和HNRNPL为与Circ-MYOCD相互作用的RBP。在H9C2细胞中,HNRNPH1敲低显著增强而其过表达抑制Circ-MYOCD反向剪接;HNRNPH1过表达明显增加心肌肥大标志物ANP和BNP的表达,而其敲低则产生相反作用。在Ang II诱导的H9C2细胞中,HNRNPH1表达显著增加,ANP和BNP表达也增加,HNRNPH1敲低明显增加Circ-MYOCD表达,降低MYOCD表达,并降低ANP和BNP表达。

结论

HNRNPH1调节Circ-MYOCD反向剪接以影响心肌肥大的进展。

相似文献

1
[The splicing factor HNRNPH1 regulates Circ-MYOCD back-splicing to modulate the course of cardiac hypertrophy].剪接因子HNRNPH1调控Circ-MYOCD反向剪接以调节心肌肥大进程
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Mar 20;45(3):587-594. doi: 10.12122/j.issn.1673-4254.2025.03.16.
2
Circular RNA circ_0001006 aggravates cardiac hypertrophy via miR-214-3p/PAK6 axis.环状 RNA circ_0001006 通过 miR-214-3p/PAK6 轴加重心肌肥厚。
Aging (Albany NY). 2022 Mar 6;14(5):2210-2220. doi: 10.18632/aging.203461.
3
A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway.一种新型 circ_0018553 通过调节 miR-4731/SIRT2 信号通路来防止血管紧张素诱导的心肌细胞肥大。
Hypertens Res. 2023 Feb;46(2):421-436. doi: 10.1038/s41440-022-01111-y. Epub 2022 Dec 6.
4
Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA.环状 TLR4 通过招募 FUS 稳定 TLR4 mRNA 促进心肌肥厚。
J Interv Card Electrophysiol. 2022 Oct;65(1):153-163. doi: 10.1007/s10840-022-01209-w. Epub 2022 May 12.
5
Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis.环状核因子 IX(circNfix)通过调节 miR-145-5p/ATF3 轴减轻压力超负荷诱导的心肌肥厚。
Bioengineered. 2021 Dec;12(1):5373-5385. doi: 10.1080/21655979.2021.1960462.
6
Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway.虾青素通过靶向 METTL3/Circ_0078450/miR-338-3p/GATA4 通路缓解心肌肥厚过程。
Int Heart J. 2024;65(1):119-127. doi: 10.1536/ihj.23-423.
7
GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.GDF11 通过下调 CCL11 减轻血管紧张素 II 诱导的肥厚性心肌病和 ANP、BNP 及β-MHC 的表达。
Curr Mol Med. 2018;18(10):661-671. doi: 10.2174/1566524019666190204112753.
8
CircRNA Larp4b/miR-298-5p/Mef2c Regulates Cardiac Hypertrophy Induced by Angiotensin II.环状RNA Larp4b/微小RNA-298-5p/肌细胞增强因子2C调控血管紧张素II诱导的心肌肥大
Int J Sports Med. 2024 Jan;45(1):33-40. doi: 10.1055/a-2172-8171. Epub 2023 Nov 13.
9
CD38 promotes angiotensin II-induced cardiac hypertrophy.CD38促进血管紧张素II诱导的心肌肥大。
J Cell Mol Med. 2017 Aug;21(8):1492-1502. doi: 10.1111/jcmm.13076. Epub 2017 Mar 12.
10
Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.miR-142-3p 的过表达改善心肌肥厚中的线粒体功能。
Biomed Pharmacother. 2018 Dec;108:1347-1356. doi: 10.1016/j.biopha.2018.09.146. Epub 2018 Oct 4.

本文引用的文献

1
RNA Helicase DDX5 Maintains Cardiac Function by Regulating Alternative Splicing.RNA 解旋酶 DDX5 通过调节可变剪接维持心脏功能。
Circulation. 2024 Oct;150(14):1121-1139. doi: 10.1161/CIRCULATIONAHA.123.064774. Epub 2024 Jul 26.
2
Molecular mechanisms of circular RNA translation.环状 RNA 翻译的分子机制。
Exp Mol Med. 2024 Jun;56(6):1272-1280. doi: 10.1038/s12276-024-01220-3. Epub 2024 Jun 14.
3
Alternative splicing and related RNA binding proteins in human health and disease.可变剪接及相关 RNA 结合蛋白与人类健康和疾病。
Signal Transduct Target Ther. 2024 Feb 2;9(1):26. doi: 10.1038/s41392-024-01734-2.
4
Protein Kinase A Is a Master Regulator of Physiological and Pathological Cardiac Hypertrophy.蛋白激酶 A 是生理性和病理性心肌肥厚的主要调节因子。
Circ Res. 2024 Feb 16;134(4):393-410. doi: 10.1161/CIRCRESAHA.123.322729. Epub 2024 Jan 26.
5
Improved modeling of RNA-binding protein motifs in an interpretable neural model of RNA splicing.改进 RNA 剪接神经网络模型中 RNA 结合蛋白基序的可解释建模。
Genome Biol. 2024 Jan 16;25(1):23. doi: 10.1186/s13059-023-03162-x.
6
Structural insights into branch site proofreading by human spliceosome.人类剪接体的分支位点校对的结构见解
Nat Struct Mol Biol. 2024 May;31(5):835-845. doi: 10.1038/s41594-023-01188-0. Epub 2024 Jan 9.
7
Exercise-induced circular RNA circUtrn is required for cardiac physiological hypertrophy and prevents myocardial ischaemia-reperfusion injury.运动诱导的环状 RNA circUtrn 是心脏生理性肥大所必需的,可防止心肌缺血再灌注损伤。
Cardiovasc Res. 2023 Dec 19;119(16):2638-2652. doi: 10.1093/cvr/cvad161.
8
Towards understandings of serine/arginine-rich splicing factors.迈向对富含丝氨酸/精氨酸剪接因子的理解。
Acta Pharm Sin B. 2023 Aug;13(8):3181-3207. doi: 10.1016/j.apsb.2023.05.022. Epub 2023 May 23.
9
The Microenvironment of the Pathogenesis of Cardiac Hypertrophy.心肌肥厚发病机制的微环境。
Cells. 2023 Jul 4;12(13):1780. doi: 10.3390/cells12131780.
10
The regulation of circRNA and lncRNAprotein binding in cardiovascular diseases: Emerging therapeutic targets.环状 RNA 和长链非编码 RNA 与蛋白质相互作用在心血管疾病中的调控:新兴的治疗靶点。
Biomed Pharmacother. 2023 Sep;165:115067. doi: 10.1016/j.biopha.2023.115067. Epub 2023 Jun 29.